Fake doc gets house arrest, must repay $590k in $19M Medicare fraud case

New Jersey cardiologist sentenced to 6.5 years, must repay $19M for Medicare fraud scheme

An accomplice in the largest Medicare fraud scheme in New Jersey history was sentenced yesterday to 8 months of house arrest and ordered to pony up nearly $590,000 in restitution, according to court documents.

Mario Roncal was a key part of the scheme designed by prominent New Jersey cardiologist Dr. Jose Katz, who was sentenced last week to 6½ years in prison and ordered to repay the $19 million in fraudulent reimbursements he reaped.

Katz was co-founder and CEO of a pair of cardiology and internal medicine businesses in New Jersey and New York, according to court documents.

In April, Katz admitted to drumming up more business than he could personally handle via a more than $6 million Spanish-language advertising campaign, "which attracted hundreds of patients to the Katz companies every day," according to the documents. He used the influx of patients to order unnecessary blood tests and compression treatments for faked diagnoses of angina. Katz also created a no-show job for his wife that generated nearly $1.3 million in faked earnings.

To satisfy demand generated by the ad campaign, Katz hired Roncal, a graduate of Puerto Rico’s San Juan Bautista School of Medicine but not a licensed physician in either New Jersey or New York because the school is not accredited. Roncal, who pleaded guilty earlier this year, masqueraded as a physician at the Katz clinics, going to far as to forge Katz’s signature in patient records and insurance forms and ordering unneeded tests and procedures.

Katz created a 30-test "basic profile blood panel" and ordered it for every patient in his 5 clinics "irrespective of the reason the patient had sought medical care, whether the examining physician had ordered the panel, or whether the tests on the panel were reasonable and necessary for the treatment or diagnosis of the patient," according to the documents. Katz admitted to falsifying patients’ records "with fictitious and boilerplate symptoms" to "falsely diagnose a majority of his Medicare and Medicaid patients with angina to justify prescribing unnecessary [enhanced external counterpulsation] treatments for those patients," according to the documents.

EECP treatments involve cyclical compression of the lower trunk and legs, typically via 35 1-hour treatments. But Medicare will cover the treatments only for diagnoses of "disabling stable angina that was inoperable or for which surgery would be highly risky."

"In fact, defendant Katz prescribed EECP treatments for patients even though some of those patients had contraindications for the treatment," according to the documents. "From in or about 2005, through in or about 2012, Medicare and Medicaid paid the Katz Companies more than approximately $15.6 million for EECP treatments."

The government insurance programs alone paid out $70 million to the Katz clinics from 2005 to 2012, including $15.6 million for medically unnecessary EECP treatments. Katz admitted to $19.3 million worth of fraudulent Medicare and Medicaid income.

RSS From Medical Design & Outsourcing

  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]
  • MasterControl’s CEO talks EQMS software and new partnerships
    MasterControl offers a quality and compliance software that helps device companies speed time to market and improve their bottom lines. Under Jon’s leadership, the company has blossomed into a market leader and has a unique corporate culture that fosters growth, excellence and quality. In this podcast, MasterControl’s CEO, Jon Beckstrand, will discuss electronic quality management […]
  • BIT Group launches white label IVD solutions
    BIT Group has launched a product line of customizable IVD white label instruments. During recent years, BIT has invested capital and resources developing customizable, ready-to-use IVD systems to address a growing demand. “The IVD market is challenging for our clients,” said Marius Balger, CEO at BIT. “OEM’s must adhere to a growing number of evolving IVD […]
  • Toshiba expands line-up of ARM Cortex-M-based microcontrollers
    Toshiba announced that it has enhanced its current “TX Family” of ARM core-based microcontrollers and started to develop three series of microcontrollers, “TXZ0 series,” “TXZ3 series” and “TXZ4 series,” as part of the “TXZTM Family.” The TXZTM Family is a new collection of flash microcontrollers that support low-power consumption and high-speed operation for IoT and M2M […]
  • Parker Hannifin consolidates, layoffs ahead
    Parker Hannifin plans to consolidate a number of internal divisions, close 2 facilities and expand its Mexican operations, according to an internally distributed letter from Andy Ross, Parker’s engineered materials group president. The company has confirmed the letter was authentic, but has not disclosed how many employees will be affected by the new plans or […]
  • 3-phase current transducer from PEM delivers all-in-one convenience
    The new RCTrms 3-ph current transducer from Power Electronic Measurements (PEM) delivers a convenient, safe and accurate solution for measuring current in three phases. It features a thin, clip-around, flexible sensor coil and provides accurate true rms measurement with 4-20 mA or 0-5 V output, enabling simple installation with PLC’s, SCADA systems or automation equipment. […]
  • Safety alert: Recall on two IV solutions from Baxter
    Baxter International announced it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital and user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to […]
  • TSO3 begins shipment of STERIZONE VP4 Sterilizers to U.S.
    TSO3, a developer in sterilization technology for medical devices in healthcare settings, announced that the company has received purchase orders for multiple devices from the U.S. The orders are the result of the collaborative relationship between Getinge Infection Control, its sales and service provider, and TSO3. “Finally,” said R.M. Rumble, president and CEO of TSO3. “Our Vision is […]
  • Turkish medical company is seeking reseller and OEM partners in the U.S.
    UZUMCU Medical Equipment, one of Turkey’s first and largest manufacturers of medical devices, is seeking reseller and OEM partners in the U.S. The company has an array of FDA-certified OR tables, surgical lights, surgical suction units, electro devices and other medical equipment. “We want to bring our experience with distributors throughout Europe and the Middle […]
  • QImaging introduces new CCD cameras for microscopy with modern software to streamline image capture
    QImaging, a manufacturer of scientific cameras for life science and OEM applications, introduces a new series of Retiga CCD cameras, accompanied by QImaging’s new acquisition software to deliver high-performance tools for microscopy and imaging to researchers at an affordable price. The new QImaging Retiga R1, Retiga R3 and Retiga R6 cameras offer valuable technical features […]

Leave a Reply